Screenshots

Description

INVESTIGATIONAL DEVICE - Only available for participants in the ongoing clinical investigation. Check if you are able to enroll here: www.vicorecompanionstudy.com

Almee (an investigational medical device pending FDA clearance) is a digital therapeutic intended to provide cognitive behavioral therapy (CBT) to address symptoms of anxiety and to improve the quality of life in patients aged 22 and older with pulmonary fibrosis (PF).

How Almee works
The treatment takes nine weeks to complete and consists of seven Therapy modules and three Essentials modules. In the therapy program, you’ll learn about various topics such as motivation, feelings and behaviors, values and living in line with your personal values, mindfulness, dealing with troubling thoughts, and much more. The Essentials modules contain tools and information about physical activity, better sleep and nutrition, and how to manage PF symtoms. You’ll go through the Therapy modules sequentially, one by one, while you can work with the Essentials modules at any time.

For more information about Almee, visit almeetherapy.com

What’s New

Version 1.1.1

Bug fixes and improvements.

App Privacy

The developer, Alex Therapeutics AB, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Linked to You

The following data may be collected and linked to your identity:

  • Location
  • Contact Info
  • Identifiers
  • Usage Data
  • Diagnostics

Privacy practices may vary based on, for example, the features you use or your age. Learn More

You Might Also Like

Curebase
Medical
PATTERN: Mood Journal Decoder
Health & Fitness
attune Ensemble™
Medical
My Valve My Voice
Health & Fitness
HealthXL
Medical
ATS 2022 Wellness Challenge
Health & Fitness